The Quidel Triage BNP test is a rapid, easy-to-use, point-of-care fluorescence immunoassay to be used with the Quidel Triage meters for the quantitative measurement of B-type natriuretic peptide (BNP) in EDTA anticoagulated whole blood or plasma specimens. The test is intended to be used as an aid in the diagnosis and assessment of severity of congestive heart failure (also referred to as heart failure). The test also is used for the risk stratification of patients with acute coronary syndromes and for the risk stratification of patients with heart failure.
Need more information?
98000XR – BNP test
98013XR (Global) – BNP control 1
98014XR (Global) – BNP control 2
98015XR (Global) – BNP calibration validation
88753 (Global) – Total 5 control 1
88754 (Global) – Total 5 control 2
88755 (Global) – Total 5 calibration verification
The Quidel Triage BNP test is a rapid, easy-to-use, point-of-care fluorescence immunoassay to be used with the Quidel Triage meters for the quantitative measurement of B-type natriuretic peptide (BNP) in EDTA anticoagulated whole blood or plasma specimens. The test is intended to be used as an aid in the diagnosis and assessment of severity of congestive heart failure (also referred to as heart failure). The test also is used for the risk stratification of patients with acute coronary syndromes and for the risk stratification of patients with heart failure.
Need more information?
98000XR – BNP test
98013XR (Global) – BNP control 1
98014XR (Global) – BNP control 2
98015XR (Global) – BNP calibration validation
88753 (Global) – Total 5 control 1
88754 (Global) – Total 5 control 2
88755 (Global) – Total 5 calibration verification
Features & benefits
Rapid results in approximately 15 minutes
The only CLIA-waived BNP test on the market for whole blood testing
Improves workflow efficiency to allow you to quickly evaluate patient status
Administer this test at the point of care, allowing clinicians to immediately consult with their patients on test results.
Rapidly evaluate patients with symptoms like shortness of breath or fatigue, facilitating diagnosis and assessment of severity of heart failure thereby enabling timely decisions on guideline-directed medical therapy or hospital-based care.
Administer this test at the point of care, allowing clinicians to immediately consult with their patients on test results.
Rapidly evaluate patients with symptoms like shortness of breath or fatigue, facilitating diagnosis and assessment of severity of heart failure thereby enabling timely decisions on guideline-directed medical therapy or hospital-based care.
To access safety data sheets, package inserts, quick reference guides and all other technical and promotional materials, visit our technical documents library.
- Quick links
- Specifications
| Product specifications | |
| Sample type | Plasma or whole blood in EDTA |
| Time to results | Yields results in about 15-20 minutes |
| CLIA complexity | Waived for whole blood |
Run your lab at peak performance
From allocating your staff and tracking their training to systematic reporting for administrators and regulators, our customer experience program can help you harness the power of your people. Working together, we can keep your lab’s team, tools and data aligned and on the same page through every minute and every test of every day.
Related products
